PARP Inhibitors : Current and Future Options for Breast and Ovarian Cancer

This activity is designed to aid physicians in assessing the use of PARP inhibitors for ovarian cancer and for referrals for clinical trials for breast cancer, including patient-specific treatment regimens and monitoring for adverse events during therapy, and applying these data to their practices.